uk ru en
LIFE SCIENCES LAWYERS | UKRAINE & CIS
Menu

LEGAL ALLIANCE, founded in 1995, is today one of the leading Ukrainian law firms specializing in legal support to pharmaceutical companies doing business in Ukraine and CIS countries.

OUR CLIENTS represent the following industries: pharmaceuticals, medical devices, consumer goods, medicine, cosmetics, para-pharmaceuticals, chemistry, biotechnology, agriculture and food products.

LEADING ASSOCIATIONS — AIPM Ukraine, APRaD as well as the EBA Healthcare Committee have chosen Legal Alliance as their legal advisor.

955
Advertise medicines or not: what does the new draft prescribe?
On January 21, a draft order on amendments to criteria applied to determine medicines which cannot be advertised draft was published. Andrii Gorbatenko analyzed the pros and cons of this document for the pharmaceutical market.
927
The law on the extension of the autonomization of clinics does not eliminate the reluctance of some local authorities and chief physicians to change methods of work
On peculiarities of the law to extend the autonomization clinics (Bill №2428), which will allow medical institutions to enter the medical reform, said counsel at Legal Alliance Company Vitalii Savchuk, especially for the news agency "Interfax-Ukraine".
1086
​Draft legislation on reducing pressure on business by market surveillance authorities makes duplication of supervision impossible – lawyers
The draft legislation on reducing pressure on business by market surveillance authorities makes it impossible to duplicate the supervision of one and the same enterprise, think the lawyers of Legal Alliance Company Illya Kostin and Victoria Malyniak.
2189
​New criterion for evaluating tender proposals - life cycle cost
Lawyer and Law, No. 43, November 28th, 2019 Ivanna Nepyivoda, assistant associate, Legal Alliance Company Recently, Law of Ukraine No. 114-IX "On Amending the
2216
Changing approaches to medicines patenting: market participants discussed key innovations
On November 4th, Legal Alliance Company with the support of the Association of Innovative Drug Manufacturers “APRaD” held the discussion club “Discussion Pharma MeetUP on Intellectual Property: Manufacturers of Innovative Drugs vs Generics Manufacturers on Bills No. 2089 and No. 2259.” Details of the discussion in the article from Apteka.ua.

If you find out a mistake, please, mark it and select Ctrl+Enter to inform us